Ignite Creation Date:
2025-12-24 @ 5:23 PM
Ignite Modification Date:
2026-02-11 @ 8:38 PM
Study NCT ID:
NCT00676650
Status:
TERMINATED
Last Update Posted:
2013-03-08
First Post:
2008-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-07
Start Date Type:
None
Primary Completion Date:
2011-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-12
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-08
First Submit QC Date:
None
Study First Post Date:
2008-05-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-12-20
Results First Submit QC Date:
None
Results First Post Date:
2013-03-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-02-05
Last Update Post Date:
2013-03-08
Last Update Post Date Type:
ESTIMATED